Utilisation of industrial biotechnology methods for differential diagnostic of neurological diseases
Project goals
The aim of the project is the development of a multiparametric diagnostic kit and prototypes of kits for the determination of auto-antibodies against selected antigens, which will be used in the differential diagnosis of selected neurological diseases, namely in the diagnosis of dementia - Alzheimer's disease. Parkinson's disease (PN), Fronto-temporal neurodegeneration (FTLD), Lewys body dementia (DLB) and vascular dementia (VD).
Keywords
Public support
Provider
Ministry of Industry and Trade
Programme
—
Call for proposals
—
Main participants
VIDIA spol. s r.o.
Contest type
OP - EU Operational Programme
Contract ID
MPO 58637/19/61200/801
Alternative language
Project name in Czech
Využití metod průmyslové biotechnologie pro diferenciální diagnostiku neurologických onemocnění
Annotation in Czech
Cílem projektu je vývoj multiparametrické diagnostické soupravy a prototypů souprav na stanovení auto-protilátek proti vybraným antigenů, které se ve vhodné kombinaci a dle stanoveného modelu aktivity definovaných biomarkerů uplatní v diferenciální diagnostice vybraných neurologických onemocnění, konkrétně v diagnostice demence - Alzheimerovy nemoci (AN), Parkinsonovy nemoci (PN), Fronto-temporální neurodegenerace (FTLD), Lewys body demence (DLB) a vaskulární demence (VD).
Scientific branches
R&D category
VV - Exeperimental development
OECD FORD - main branch
30403 - Technologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions [pharmacogenomics, gene-based therapeutics])
OECD FORD - secondary branch
—
OECD FORD - another secondary branch
—
EI - Biotechnology and bionics
Completed project evaluation
Provider evaluation
U - Uspěl podle zadání (s publikovanými či patentovanými výsledky atd.)
Project results evaluation
The project met the expected outputs.
Solution timeline
Realization period - beginning
Jul 1, 2019
Realization period - end
Dec 30, 2022
Project status
U - Finished project
Latest support payment
Oct 21, 2022
Data delivery to CEP
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data delivery code
CEP23-MPO-EG-U
Data delivery date
Jul 17, 2023
Finance
Total approved costs
7,890 thou. CZK
Public financial support
0 thou. CZK
Other public sources
0 thou. CZK
Non public and foreign sources
2,367 thou. CZK
Basic information
Provider
Ministry of Industry and Trade
OECD FORD
Technologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions [pharmacogenomics, gene-based therapeutics])
Solution period
01. 07. 2019 - 30. 12. 2022